Human RAGE GLY82SER dimorphism and HLA class II DRB1-DQA1-DQB1 haplotypes in type 1 diabetes

Citation
G. Prevost et al., Human RAGE GLY82SER dimorphism and HLA class II DRB1-DQA1-DQB1 haplotypes in type 1 diabetes, EUR J IMM, 26(5), 1999, pp. 343-348
Citations number
36
Categorie Soggetti
Immunology
Journal title
EUROPEAN JOURNAL OF IMMUNOGENETICS
ISSN journal
09607420 → ACNP
Volume
26
Issue
5
Year of publication
1999
Pages
343 - 348
Database
ISI
SICI code
0960-7420(199910)26:5<343:HRGDAH>2.0.ZU;2-K
Abstract
Advanced glycation end products (AGEs) are believed to play an important ro le in the development of diabetic complications. AGEs increase in diabetes and modulate cellular functions through binding to a specific cell surface receptor (RAGE). The RAGE gene maps to chromosome 6p in the HLA class III a rea and is telomeric to the class IT region at 250 kb from DRA. A recent re port described the characterization of a major RAGE gene variant as a biall elic single base polymorphism (G/A 557) in the exon 3 sequence leading to a change of a glycine to a serine at position 82. Using DGGE and PCR-RFLP, w e have investigated the distribution of this dimorphism in conjunction with HLA class II genes in large populations of type 1 diabetic patients and he althy subjects. Although no association of this RAGE gene polymorphism with disease susceptibility was found, we report a strong linkage disequilibriu m between the variant carrying the serine amino acid at position 82 and two HLA-DR2 and HLA-DR4 specificities. In particular, we describe two major ex tensive HLA class II haplo-types associated with this serine variant and id entified as DRB1*0401-DQA1*0301-DQB1*0301 in the diabetic group and DRB1*'1 501-DQA1*0102-DQB1*0602 in control individuals. These data were partially c onfirmed by family transmission analysis.